.12 March 2021The Vall d ´Hebron Institute of Oncology (VHIO) Seeks a "Postdoctoral Researcher in Computational Biology"Reference : Ref. 17-2021Application deadline : Application open until filled.Number of vacancies : 1Job description : The new Cancer Computational Biology group (PI Jose A. Seoane) at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona (Spain) is looking for a computational biologist to fill a Postdoctoral position. Research projects may involve, but are not limited to:Epigenetic data analysis : What is the role of epigenetic modifications in drug resistance, cancer progression, or metastasis?Multi-omic analysis : Application or development of tools that successfully integrate different modalities of genomic or clinical data.Biomarker discovery : Development of new biomarkers of cancer progression, drug resistance, and metastasis using machine learning techniques.We offer a two-year appointment with a possible extension of one year.Requirements : Language requirements: English.Application :Cover letter with previous research experience, current and future research interest, including expected starting date.CVNames and contacts of 2 referees.About VHIO : Under the leadership of Josep Tabernero, the Vall d'Hebron Institute of Oncology (VHIO) has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease. Located within the Vall d'Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d'Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients. VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.Vall d'Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies. On 10th April 2018, VHIO was awarded the "HR Excellence in Research" logo